Progesterone Function in Human Endometrium: Clinical Perspectives

ABSTRACT

Progesterone is essential for endometrial receptivity and successful establishment of pregnancy. Either an insufficient progesterone concentration or an insufficient response to progesterone, therefore can lead to infertility and pregnancy loss. Assessment of the role that either progesterone insufficiency or inadequate progesterone response plays in human reproductive failure has been difficult to assess because serum progesterone concentrations fluctuate markedly, limiting the ability to characterize sufficiency of progesterone, and there are no highly reliable markers of endometrial function available. Recent evidence demonstrates exquisite sensitivity of normal endometrium to very low levels of progesterone stimulation, suggesting that progesterone insufficiency should not be a common cause of reproductive failure. Further evidence suggests that women with endometriosis, and possibly polycystic ovarian syndrome, have an altered progesterone response, which may explain some of the clinical features of these disorders and supports the hypothesis that progesterone resistance underlies some cases of human reproductive failure.

KEYWORDS

Luteal phase defect - progesterone resistance - endometrium - embryo implantation - endometriosis

REFERENCES

• 1 Gellersen B, Fernandes M S, Brosens J J. Non-genomic progesterone actions in female reproduction.  Hum Reprod Update. 2009; 
• 2 Klein M. [Berthold's article: Transplantation of the testes (1849)].  Arch Anat Histol Embryol. 1968;  51(1) 379-386
• 3 Allen E, Doisey E A. Landmark article Sept. 8, 1923. An ovarian hormone: preliminary report on its localization, extraction and partial purification, and action in test animals.  JAMA. 1983;  250 2681-2683
• 4 Hisaw F L, Meyer R K, Weichert C K. Inhibition of ovulation and associated histologic changes.  Proc Soc Exp Biol Med. 1928;  20 754-756
• 5 Hisaw F L, Leonard S L. Production of a premenstrual endometrium in castrated monkeys by ovarian hormones.  Proc Soc Exp Biol Med. 1930;  27 400-403
• 6 Allen W M, Corner G W. Physiology of the corpus luteum.  Am J Obstet Gynecol. 2005;  193 1574
• 7 Jensen E V, DeSombre E R. Estrogen-receptor interaction.  Science. 1973;  182 126-134
• 8 Gorski J, Toft D, Shyamala G, Smith D, Notides A. Hormone receptors: studies on the interaction of estrogen with the uterus.  Recent Prog Horm Res. 1968;  24 45-80
• 9 O'Malley B W, Sherman M R, Toft D O. Progesterone “receptors” in the cytoplasm and nucleus of chick oviduct target tissue.  Proc Natl Acad Sci U S A. 1970;  67 501-508
• 10 O'Malley B W, Means A R. Female steroid hormones and target cell nuclei.  Science. 1974;  183(125) 610-620
• 11 Mueller G C, Herranen A M, Jervell K F. Studies on the mechanism of action of estrogens.  Recent Prog Horm Res. 1958;  14 95-129 discussion 130-129
• 12 Jensen E V. Proceedings of the 4th International Congress of Biochemistry Vol 15 Oxford, United Kingdom; Pergamon Press 1958
• 13 Jensen E V, Jacobson H I. Fate of steroid receptor estrogens in target tissues. In: Pincus G, Vollmer EP Biological Activities of Steroids in Relation to Cancer. New York, NY; Academic Press 1960
• 14 Jensen E V, DeSombre E R. Estrogen-receptor interaction.  Science. 1973;  182 126-134
• 15 Lubahn D B, Moyer J S, Golding T S, Couse J F, Korach K S, Smithies O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene.  Proc Natl Acad Sci U S A. 1993;  90(23) 11162-11166
• 16 Korach K S. Insights from the study of animals lacking functional estrogen receptor.  Science. 1994;  266(5190) 1524-1527
• 17 Smith E P, Boyd J, Frank G R et al.. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man.  N Engl J Med. 1994;  331(16) 1056-1061
• 18 Korach K S. Insights from the study of animals lacking functional estrogen receptor.  Science. 1994;  266(5190) 1524-1527
• 19 Conneely O M, Mulac-Jericevic B, DeMayo F, Lydon J P, O'Malley B W. Reproductive functions of progesterone receptors.  Recent Prog Horm Res. 2002;  57 339-355
• 20 Cooke P S, Buchanan D L, Lubahn D B, Cunha G R. Mechanism of estrogen action: lessons from the estrogen receptor-α knockout mouse.  Biol Reprod. 1998;  59(3) 470-475
• 21 Kurita T, Lee K J, Cooke P S, Taylor J A, Lubahn D B, Cunha G R. Paracrine regulation of epithelial progesterone receptor by estradiol in the mouse female reproductive tract.  Biol Reprod. 2000;  62(4) 821-830
• 22 Kurita T, Young P, Brody J R, Lydon J P, O'Malley B W, Cunha G R. Stromal progesterone receptors mediate the inhibitory effects of progesterone on estrogen-induced uterine epithelial cell deoxyribonucleic acid synthesis.  Endocrinology. 1998;  139(11) 4708-4713
• 23 Milin B, Roy A K. Androgen “receptor” in rat liver: cytosol “receptor” deficiency in pseudohermaphrodite male rats.  Nat New Biol. 1973;  242(121) 248-250
• 24 Brown T R, Lubahn D B, Wilson E M, Joseph D R, French F S, Migeon C J. Deletion of the steroid-binding domain of the human androgen receptor gene in one family with complete androgen insensitivity syndrome: evidence for further genetic heterogeneity in this syndrome.  Proc Natl Acad Sci U S A. 1988;  85(21) 8151-8155
• 25 Erickson G F, Yen S SC. The polycystic ovary syndrome. In: Adashi EY, Leung PCK The Ovary. New York, NY; Raven Press 1993
• 26 Franks S. Polycystic ovary syndrome.  Arch Dis Child. 1997;  77(1) 89-90
• 27 Homburg R. Polycystic ovary syndrome.  Best Pract Res Clin Obstet Gynaecol. 2008;  22 261-274
• 28 Navaratnarajah R, Pillay O C, Hardiman P. Polycystic ovary syndrome and endometrial cancer.  Semin Reprod Med. 2008;  26(1) 62-71
• 29 Fritz M A, Lessey B A. Defective luteal function. In: Fraser IS Estrogens and Progestogens in Clinical Practice. Vol 1. London, United Kingdom; Churchill Livingstone 1998
• 30 Jones G E. Some newer aspects of the management of infertility.  J Am Med Assoc. 1949;  141 1123-1129
• 31 Burney R O, Talbi S, Hamilton A E et al.. Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis.  Endocrinology. 2007;  148(8) 3814-3826
• 32 Lessey B A, Killam A P, Metzger D A, Haney A F, Greene G L, McCarty Jr K S. Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle.  J Clin Endocrinol Metab. 1988;  67(2) 334-340
• 33 Talbi S, Hamilton A E, Vo K C et al.. Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women.  Endocrinology. 2006;  147(3) 1097-1121
• 34 Catalano R D, Critchley H O, Heikinheimo O et al.. Mifepristone induced progesterone withdrawal reveals novel regulatory pathways in human endometrium.  Mol Hum Reprod. 2007;  13(9) 641-654
• 35 Joshi S G, Ebert K M, Smith R A. Properties of the progestagen-dependent protein of the human endometrium.  J Reprod Fertil. 1980;  59(2) 287-296
• 36 Joshi S G, Ebert K M, Swartz D P. Detection and synthesis of a progestagen-dependent protein in human endometrium.  J Reprod Fertil. 1980;  59(2) 273-285
• 37 Joshi S G. Progestin-regulated proteins of the human endometrium.  Semin Reprod Endocrinol. 1983;  1 221
• 38 Julkunen M, Raikar R S, Joshi S G, Bohn H, Seppälä M. Placental protein 14 and progestagen-dependent endometrial protein are immunologically indistinguishable.  Hum Reprod. 1986;  1(1) 7-8
• 39 Bohn H, Kraus W. Isolation and characterization of a new placenta specific protein (PP12).  Arch Gynecol. 1980;  229 279-291
• 40 Rutanen E M, Koistinen R, Seppälä M, Julkunen M, Suikkari A M, Huhtala M L. Progesterone-associated proteins PP12 and PP14 in the human endometrium.  J Steroid Biochem. 1987;  27(1-3) 25-31
• 41 Bischof P. Three pregnancy proteins (PP12, PP14, and PAPP-A): their biological and clinical relevance.  Am J Perinatol. 1989;  6(2) 110-116
• 42 Julkunen M, Koistinen R, Sjöberg J, Rutanen E M, Wahlström T, Seppälä M. Secretory endometrium synthesizes placental protein 14.  Endocrinology. 1986;  118(5) 1782-1786
• 43 Rutanen E M, Koistinen R, Sjöberg J et al.. Synthesis of placental protein 12 by human endometrium.  Endocrinology. 1986;  118(3) 1067-1071
• 44 Giudice L C, Lamson G, Rosenfeld R G, Irwin J C. Insulin-like growth factor-II (IGF-II) and IGF binding proteins in human endometrium.  Ann N Y Acad Sci. 1991;  626 295-307
• 45 Seppälä M, Koistinen R, Rutanen E M. Uterine endocrinology and paracrinology: insulin-like growth factor binding protein-1 and placental protein 14 revisited.  Hum Reprod. 1994;  9(5) 917-925
• 46 Rutanen E M, Pekonen F, Nyman T, Wahlström T. Insulin-like growth factors and their binding proteins in benign and malignant uterine diseases.  Growth Regul. 1993;  3(1) 74-77
• 47 Giudice L C, Dsupin B A, Jin I H, Vu T H, Hoffman A R. Differential expression of messenger ribonucleic acids encoding insulin-like growth factors and their receptors in human uterine endometrium and decidua.  J Clin Endocrinol Metab. 1993;  76(5) 1115-1122
• 48 Bell S C. The insulin-like growth factor binding proteins—the endometrium and decidua.  Ann N Y Acad Sci. 1991;  622 120-137
• 49 Tseng L, Gao J G, Chen R, Zhu H H, Mazella J, Powell D R. Effect of progestin, antiprogestin, and relaxin on the accumulation of prolactin and insulin-like growth factor-binding protein-1 messenger ribonucleic acid in human endometrial stromal cells.  Biol Reprod. 1992;  47(3) 441-450
• 50 Irwin J C, de las Fuentes L, Giudice L C. Growth factors and decidualization in vitro.  Ann N Y Acad Sci. 1994;  734 7-18
• 51 Frost R A, Mazella J, Tseng L. Insulin-like growth factor binding protein-1 inhibits the mitogenic effect of insulin-like growth factors and progestins in human endometrial stromal cells.  Biol Reprod. 1993;  49(1) 104-111
• 52 Irwin J C, Suen L F, Martina N A, Mark S P, Giudice L C. Role of the IGF system in trophoblast invasion and pre-eclampsia.  Hum Reprod. 1999;  14(Suppl 2) 90-96
• 53 Li T C, Dalton C, Hunjan K S, Warren M A, Bolton A E. The correlation of placental protein 14 concentrations in uterine flushing and endometrial morphology in the peri-implantation period.  Hum Reprod. 1993;  8(11) 1923-1927
• 54 Klentzeris L D, Bulmer J N, Seppälä M, Li T C, Warren M A, Cooke I D. Placental protein 14 in cycles with normal and retarded endometrial differentiation.  Hum Reprod. 1994;  9(3) 394-398
• 55 Dalton C F, Laird S M, Serle E et al.. The measurement of CA 125 and placental protein 14 in uterine flushings in women with recurrent miscarriage; relation to endometrial morphology.  Hum Reprod. 1995;  10(10) 2680-2684
• 56 Oehninger S, Coddington C C, Hodgen G D, Seppala M. Factors affecting fertilization: endometrial placental protein 14 reduces the capacity of human spermatozoa to bind to the human zona pellucida.  Fertil Steril. 1995;  63(2) 377-383
• 57 Clark G F, Oehninger S, Patankar M S et al.. A role for glycoconjugates in human development: the human feto-embryonic defence system hypothesis.  Hum Reprod. 1996;  11(3) 467-473
• 58 Karande A A, Mukhopadhyay D, Jayachandran R, Sundarraj S, Alok A. Mechanism of the immunomodulatory activity of glycodelin.  Indian J Physiol Pharmacol. 2005;  49(3) 271-283
• 59 Alok A, Mukhopadhyay D, Karande A A. Glycodelin A, an immunomodulatory protein in the endometrium, inhibits proliferation and induces apoptosis in monocytic cells.  Int J Biochem Cell Biol. 2009;  41(5) 1138-1147
• 60 Seppälä M, Taylor R N, Koistinen H, Koistinen R, Milgrom E. Glycodelin: a major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiation.  Endocr Rev. 2002;  23(4) 401-430
• 61 Stavreus-Evers A, Mandelin E, Koistinen R et al.. Glycodelin is present in pinopodes of receptive-phase human endometrium and is associated with down-regulation of progesterone receptor B.  Fertil Steril. 2006;  85(6) 1803-1811
• 62 Hasty L A, Lessey B A, Pruksananonda K et al.. The hormonal regulation of complement components throughout the menstrual cycle.  Proc of the Soc Gynecol Invest. 1992; 
• 63 Hasty L A, Brockman W W, Lambris J D, Lyttle C R. Hormonal regulation of complement factor B in human endometrium.  Am J Reprod Immunol. 1993;  30(2-3) 63-67
• 64 Hasty L A, Lambris J D, Lessey B A, Pruksananonda K, Lyttle C R. Hormonal regulation of complement components and receptors throughout the menstrual cycle.  Am J Obstet Gynecol. 1994;  170(1 Pt 1) 168-175
• 65 Young S L, Lessey B A, Fritz M A et al.. In vivo and in vitro evidence suggest that HB-EGF regulates endometrial expression of human decay-accelerating factor.  J Clin Endocrinol Metab. 2002;  87(3) 1368-1375
• 66 Apparao K B, Murray M J, Fritz M A et al.. Osteopontin and its receptor alphavbeta(3) integrin are coexpressed in the human endometrium during the menstrual cycle but regulated differentially.  J Clin Endocrinol Metab. 2001;  86(10) 4991-5000
• 67 Lessey B A, Castelbaum A J. Integrins and implantation in the human.  Rev Endocr Metab Disord. 2002;  3(2) 107-117
• 68 Fedarko N S, Fohr B, Robey P G, Young M F, Fisher L W. Factor H binding to bone sialoprotein and osteopontin enables tumor cell evasion of complement-mediated attack.  J Biol Chem. 2000;  275(22) 16666-16672
• 69 Fisher L W, Torchia D A, Fohr B, Young M F, Fedarko N S. Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin.  Biochem Biophys Res Commun. 2001;  280(2) 460-465
• 70 Jain A, Karadag A, Fohr B, Fisher L W, Fedarko N S. Three SIBLINGs (small integrin-binding ligand, N-linked glycoproteins) enhance factor H's cofactor activity enabling MCP-like cellular evasion of complement-mediated attack.  J Biol Chem. 2002;  277(16) 13700-13708
• 71 Isaacson K B, Coutifaris C, Garcia C R, Lyttle C R. Production and secretion of complement component 3 by endometriotic tissue.  J Clin Endocrinol Metab. 1989;  69(5) 1003-1009
• 72 Isaacson K B, Galman M, Coutifaris C, Lyttle C R. Endometrial synthesis and secretion of complement component-3 by patients with and without endometriosis.  Fertil Steril. 1990;  53(5) 836-841
• 73 Tao X J, Sayegh R A, Isaacson K B. Increased expression of complement component 3 in human ectopic endometrium compared with the matched eutopic endometrium.  Fertil Steril. 1997;  68(3) 460-467
• 74 Holers V M, Girardi G, Mo L et al.. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss.  J Exp Med. 2002;  195(2) 211-220
• 75 Xu C, Mao D, Holers V M, Palanca B, Cheng A M, Molina H. A critical role for murine complement regulator Crry in fetomaternal tolerance.  Science. 2000;  287(5452) 498-501
• 76 Molina H. The murine complement regulator Crry: new insights into the immunobiology of complement regulation.  Cell Mol Life Sci. 2002;  59(2) 220-229
• 77 Jorgenson R L, Young S L, Lesmeister M J, Lyddon T D, Misfeldt M L. Human endometrial epithelial cells cyclically express Toll-like receptor 3 (TLR3) and exhibit TLR3-dependent responses to dsRNA.  Hum Immunol. 2005;  66(5) 469-482
• 78 Fazeli A, Bruce C, Anumba D O. Characterization of Toll-like receptors in the female reproductive tract in humans.  Hum Reprod. 2005;  20(5) 1372-1378
• 79 Schaefer T M, Desouza K, Fahey J V, Beagley K W, Wira C R. Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells.  Immunology. 2004;  112(3) 428-436
• 80 Pioli P A, Amiel E, Schaefer T M, Connolly J E, Wira C R, Guyre P M. Differential expression of Toll-like receptors 2 and 4 in tissues of the human female reproductive tract.  Infect Immun. 2004;  72(10) 5799-5806
• 81 Csapo A I, Pulkkinen M. Indispensability of the human corpus luteum in the maintenance of early pregnancy. Luteectomy evidence.  Obstet Gynecol Surv. 1978;  33(2) 69-81
• 82 Baulieu E E. Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor.  Science. 1989;  245(4924) 1351-1357
• 83 Baulieu E E. RU486: a compound that gets itself talked about.  Hum Reprod. 1994;  9(Suppl 1) 1-6
• 84 Somkuti S G, Yuan L, Fritz M A, Lessey B A. Epidermal growth factor and sex steroids dynamically regulate a marker of endometrial receptivity in Ishikawa cells.  J Clin Endocrinol Metab. 1997;  82(7) 2192-2197
• 85 Kurihara I, Lee D K, Petit F G et al.. COUP-TFII mediates progesterone regulation of uterine implantation by controlling ER activity.  PLoS Genet. 2007;  3(6) e102
• 86 Lessey B A. Two pathways of progesterone action in the human endometrium: implications for implantation and contraception.  Steroids. 2003;  68(10-13) 809-815
• 87 Aplin J D, Charlton A K, Ayad S. An immunohistochemical study of human endometrial extracellular matrix during the menstrual cycle and first trimester of pregnancy.  Cell Tissue Res. 1988;  253(1) 231-240
• 88 Ruck P, Marzusch K, Kaiserling E et al.. Distribution of cell adhesion molecules in decidua of early human pregnancy. An immunohistochemical study.  Lab Invest. 1994;  71(1) 94-101
• 89 Turpeenniemi-Hujanen T, Feinberg R F, Kauppila A, Puistola U. Extracellular matrix interactions in early human embryos: implications for normal implantation events.  Fertil Steril. 1995;  64(1) 132-138
• 90 Albelda S M, Buck C A. Integrins and other cell adhesion molecules.  FASEB J. 1990;  4 2868-2880
• 91 Lessey B A, Damjanovich L, Coutifaris C, Castelbaum A, Albelda S M, Buck C A. Integrin adhesion molecules in the human endometrium. Correlation with the normal and abnormal menstrual cycle.  J Clin Invest. 1992;  90(1) 188-195
• 92 Lessey B A, Castelbaum A J, Buck C A, Lei Y, Yowell C W, Sun J. Further characterization of endometrial integrins during the menstrual cycle and in pregnancy.  Fertil Steril. 1994;  62(3) 497-506
• 93 Tabibzadeh S. Patterns of expression of integrin molecules in human endometrium throughout the menstrual cycle.  Hum Reprod. 1992;  7(6) 876-882
• 94 Damsky C, Sutherland A, Fisher S. Extracellular matrix 5: adhesive interactions in early mammalian embryogenesis, implantation, and placentation.  FASEB J. 1993;  7(14) 1320-1329
• 95 Armant D R, Kaplan H A, Mover H, Lennarz W J. The effect of hexapeptides on attachment and outgrowth of mouse blastocysts cultured in vitro: evidence for the involvement of the cell recognition tripeptide Arg-Gly-Asp.  Proc Natl Acad Sci U S A. 1986;  83(18) 6751-6755
• 96 Illera M J, Cullinan E, Gui Y, Yuan L, Beyler S A, Lessey B A. Blockade of the alpha(v)beta(3) integrin adversely affects implantation in the mouse.  Biol Reprod. 2000;  62(5) 1285-1290
• 97 Illera M J, Gui Y T, Mohammad A et al.. Perturbation of implantation rate by neutralization of the αvβ3 vitronectin receptor in rabbits.  J Soc Gynecol Invest. 1999;  379 143A
• 98 Bronson R A, Fusi F M. Integrins and human reproduction.  Mol Hum Reprod. 1996;  2(3) 153-168
• 99 Yelian F D, Yang Y, Hirata J D, Schultz J F, Armant D R. Molecular interactions between fibronectin and integrins during mouse blastocyst outgrowth.  Mol Reprod Dev. 1995;  41(4) 435-448
• 100 Jones J I, Gockerman A, Busby Jr W H, Wright G, Clemmons D R. Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence.  Proc Natl Acad Sci U S A. 1993;  90(22) 10553-10557
• 101 Schultz J F, Armant D R. β 1- and β 3-class integrins mediate fibronectin binding activity at the surface of developing mouse peri-implantation blastocysts. Regulation by ligand-induced mobilization of stored receptor.  J Biol Chem. 1995;  270(19) 11522-11531
• 102 Yelian F D, Yang Y, Hirata J D, Schultz J F, Armant D R. Molecular interactions between fibronectin and integrins during mouse blastocyst outgrowth.  Mol Reprod Dev. 1995;  41(4) 435-448
• 103 Illera M J, Lorenzo P L, Gui Y T, Beyler S A, Apparao K B, Lessey B A. A role for alphavbeta3 integrin during implantation in the rabbit model.  Biol Reprod. 2003;  68(3) 766-771
• 104 Sutherland A E, Calarco P G, Damsky C H. Developmental regulation of integrin expression at the time of implantation in the mouse embryo.  Development. 1993;  119(4) 1175-1186
• 105 Tseng L, Gurpide E. Effects of progestins on estradiol receptor levels in human endometrium.  J Clin Endocrinol Metab. 1975;  41(2) 402-404
• 106 Bulun S E, Gurates B, Fang Z et al.. Mechanisms of excessive estrogen formation in endometriosis.  J Reprod Immunol. 2002;  55(1-2) 21-33
• 107 Noble L S, Simpson E R, Johns A, Bulun S E. Aromatase expression in endometriosis.  J Clin Endocrinol Metab. 1996;  81(1) 174-179
• 108 Leon L, Bacallao K, Gabler F, Romero C, Valladares L, Vega M. Activities of steroid metabolic enzymes in secretory endometria from untreated women with polycystic ovary syndrome.  Steroids. 2008;  73(1) 88-95
• 109 Kitawaki J, Noguchi T, Amatsu T et al.. Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium.  Biol Reprod. 1997;  57(3) 514-519
• 110 Kitawaki J, Kusuki I, Koshiba H, Tsukamoto K, Honjo H. Expression of aromatase cytochrome P450 in eutopic endometrium and its application as a diagnostic test for endometriosis.  Gynecol Obstet Invest. 1999;  48(Suppl 1) 21-28
• 111 Tranguch S, Cheung-Flynn J, Daikoku T et al.. Cochaperone immunophilin FKBP52 is critical to uterine receptivity for embryo implantation.  Proc Natl Acad Sci U S A. 2005;  102(40) 14326-14331
• 112 Tranguch S, Wang H, Daikoku T, Xie H, Smith D F, Dey S K. FKBP52 deficiency-conferred uterine progesterone resistance is genetic background and pregnancy stage specific.  J Clin Invest. 2007;  117(7) 1824-1834
• 113 Usadi R S, Groll J M, Lessey B A et al.. Endometrial development and function in experimentally induced luteal phase deficiency.  J Clin Endocrinol Metab. 2008;  93(10) 4058-4064
• 114 Rock J, Bartlett M K. Biopsy studies of human endometrium, criterion of dating and information about amenorrhea, menorrhagia, and tissue ovulation.  J Am Med Assoc. 1937;  108 2022-2028
• 115 Jones G E. Some newer aspects of management of infertility.  J Am Med Assoc. 1949;  141 1123-1129
• 116 Noyes R W, Hertig A I, Rock J. Dating the endometrial biopsy.  Fertil Steril. 1950;  1 3-25
• 117 Noyes R W, Haman J O. Accuracy of endometrial dating; correlation of endometrial dating with basal body temperature and menses.  Fertil Steril. 1953;  4(6) 504-517
• 118 Castelbaum A J, Lessey B A. Insights into the evaluation of the luteal phase. In: Diamond MP Infertility and Reproductive Medicine. Vol 6. Philadelphia, PA; WB Saunders 1995: 199-213
• 119 Castelbaum A J, Wheeler J, Coutifaris C B, Mastroianni Jr L, Lessey B A. Timing of the endometrial biopsy may be critical for the accurate diagnosis of luteal phase deficiency.  Fertil Steril. 1994;  61(3) 443-447
• 120 Murray M J, Meyer W R, Zaino R J et al.. A critical analysis of the accuracy, reproducibility, and clinical utility of histologic endometrial dating in fertile women.  Fertil Steril. 2004;  81(5) 1333-1343
• 121 Scott R T, Snyder R R, Bagnall J W, Reed K D, Adair C F, Hensley S D. Evaluation of the impact of intraobserver variability on endometrial dating and the diagnosis of luteal phase defects.  Fertil Steril. 1993;  60(4) 652-657
• 122 Coutifaris C, Myers E R, Guzick D S NICHD National Cooperative Reproductive Medicine Network et al. Histological dating of timed endometrial biopsy tissue is not related to fertility status.  Fertil Steril. 2004;  82(5) 1264-1272
• 123 Castelbaum A J, Lessey B A. Insights into the evaluation of the luteal phase.  Infert Reprod Med Clin No Am. 1994;  6 199
• 124 Soules M R, McLachlan R I, Ek M, Dahl K D, Cohen N L, Bremner W J. Luteal phase deficiency: characterization of reproductive hormones over the menstrual cycle.  J Clin Endocrinol Metab. 1989;  69(4) 804-812
• 125 Li T C, Lenton E A, Dockery P, Cooke I D. A comparison of some clinical and endocrinological features between cycles with normal and defective luteal phases in women with unexplained infertility.  Hum Reprod. 1990;  5(7) 805-810
• 126 Hecht B R, Bardawil W A, Khan-Dawood F S, Dawood M Y. Luteal insufficiency: correlation between endometrial dating and integrated progesterone output in clomiphene citrate-induced cycles.  Am J Obstet Gynecol. 1990;  163(6 Pt 1) 1986-1991
• 127 Abraham G E, Maroulis G B, Marshall J R. Evaluation of ovulation and corpus luteum function using measurements of plasma progesterone.  Obstet Gynecol. 1974;  44(4) 522-525
• 128 Hull M G, Savage P E, Bromham D R, Ismail A A, Morris A F. The value of a single serum progesterone measurement in the midluteal phase as a criterion of a potentially fertile cycle (“ovulation”) derived form treated and untreated conception cycles.  Fertil Steril. 1982;  37(3) 355-360
• 129 Filicori M, Butler J P, Crowley Jr W F. Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion.  J Clin Invest. 1984;  73(6) 1638-1647
• 130 Nakajima S T, Gibson M. Pathophysiology of luteal-phase deficiency in human reproduction.  Clin Obstet Gynecol. 1991;  34(1) 167-179
• 131 Wilcox A J, Baird D D, Weinberg C R. Time of implantation of the conceptus and loss of pregnancy.  N Engl J Med. 1999;  340(23) 1796-1799
• 132 Wenner R. Les antiprolactines.  Gynecologie. 1974;  25(2) 229-231
• 133 Franks S, Murray M AF, Jequier A M, Steele S J, Nabarro J D, Jacobs H S. Incidence and significance of hyperprolactinaemia in women with amenorrhea.  Clin Endocrinol (Oxf). 1975;  4(6) 597-607
• 134 Corenblum B, Pairandeau N, Shewchuk A B. Prolactin hypersecretion and short luteal phase defects.  Obstet Gynecol. 1976;  47 486-488
• 135 Spark R F, Pallotta J, Naftolin F, Clemens R. Galactorrhea-amenorrhea syndromes: etiology and treatment.  Ann Intern Med. 1976;  84(5) 532-537
• 136 Mühlenstedt D, Bohnet H G, Hanker J P, Schneider H P. Short luteal phase and prolactin.  Int J Fertil. 1978;  23(3) 213-218
• 137 del Pozo E, Wyss H, Tollis G, Alcañiz J, Campana A, Naftolin F. Prolactin and deficient luteal function.  Obstet Gynecol. 1979;  53(3) 282-286
• 138 Edwards C RW, Forsyth I A, Besser G M. Amenorrhoea, galactorrhoea, and primary hypothyroidism with high circulating levels of prolactin.  BMJ. 1971;  3(5772) 462-464
• 139 Daly D C, Walters C A, Soto-Albors C E, Riddick D H. Endometrial biopsy during treatment of luteal phase defects is predictive of therapeutic outcome.  Fertil Steril. 1983;  40(3) 305-310
• 140 Sherman B M, Korenman S G. Measurement of plasma LH, FSH, estradiol and progesterone in disorders of the human menstrual cycle: the short luteal phase.  J Clin Endocrinol Metab. 1974;  38(1) 89-93
• 141 Homburg R, Armar N A, Eshel A, Adams J, Jacobs H S. Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome.  BMJ. 1988;  297(6655) 1024-1026
• 142 De Souza M J, Van Heest J, Demers L M, Lasley B L. Luteal phase deficiency in recreational runners: evidence for a hypometabolic state.  J Clin Endocrinol Metab. 2003;  88(1) 337-346
• 143 Practice Committee of the American Society for Reproductive Medicine . Progesterone supplementation during the luteal phase and in early pregnancy in the treatment of infertility: an educational bulletin.  Fertil Steril. 2008;  89(4) 789-792
• 144 Hubayter Z R, Muasher S J. Luteal supplementation in in vitro fertilization: more questions than answers.  Fertil Steril. 2008;  89(4) 749-758
• 145 Daya S, Gunby J L. WITHDRAWN: Luteal phase support in assisted reproduction cycles.  Cochrane Database Syst Rev. 2008;  (3) CD004830
• 146 Keller D W, Wiest W G, Askin F B, Johnson L W, Strickler R C. Pseudocorpus luteum insufficiency: a local defect of progesterone action on endometrial stroma.  J Clin Endocrinol Metab. 1979;  48(1) 127-132
• 147 McRae M A, Blasco L, Lyttle C R. Serum hormones and their receptors in women with normal and inadequate corpus luteum function.  Fertil Steril. 1984;  42(1) 58-63
• 148 Abd-el-Maeboud K H, Eissa S, Kamel A S. Altered endometrial progesterone/oestrogen receptor ratio in luteal phase defect.  Dis Markers. 1997;  13(2) 107-116
• 149 Ilesanmi A O, Hawkins D A, Lessey B A. Immunohistochemical markers of uterine receptivity in the human endometrium.  Microsc Res Tech. 1993;  25(3) 208-222
• 150 Kliman H J, Honig S, Walls D, Luna M, McSweet J C, Copperman A B. Optimization of endometrial preparation results in a normal endometrial function test (EFT) and good reproductive outcome in donor ovum recipients.  J Assist Reprod Genet. 2006;  23(7-8) 299-303
• 151 Wang B, Sheng J Z, He R H, Qian Y L, Jin F, Huang H F. High expression of L-selectin ligand in secretory endometrium is associated with better endometrial receptivity and facilitates embryo implantation in human being.  Am J Reprod Immunol. 2008;  60(2) 127-134
• 152 Domínguez F, Remohí J, Pellicer A, Simón C. Human endometrial receptivity: a genomic approach.  Reprod Biomed Online. 2003;  6(3) 332-338
• 153 Horcajadas J A, Pellicer A, Simón C. Wide genomic analysis of human endometrial receptivity: new times, new opportunities.  Hum Reprod Update. 2007;  13(1) 77-86
• 154 Tapia A, Gangi L M, Zegers-Hochschild F et al.. Differences in the endometrial transcript profile during the receptive period between women who were refractory to implantation and those who achieved pregnancy.  Hum Reprod. 2008;  23(2) 340-351
• 155 Dey S K, Lim H, Das S K et al.. Molecular cues to implantation.  Endocr Rev. 2004;  25(3) 341-373
• 156 Donaghay M, Lessey B A. Uterine receptivity: alterations associated with benign gynecological disease.  Semin Reprod Med. 2007;  25(6) 461-475
• 157 de los Santos M J, Mercader A, Galan A et al.. Implantation rates after two, three, or five days of embryo culture.  Placenta. 2003;  24(Suppl B) 13-19
• 158 Pope W F. Uterine asynchrony: a cause of embryonic loss.  Biol Reprod. 1988;  39(5) 999-1003
• 159 Achache H, Revel A. Endometrial receptivity markers, the journey to successful embryo implantation.  Hum Reprod Update. 2006;  12(6) 731-746
• 160 Aghajanova L, Hamilton A E, Giudice L C. Uterine receptivity to human embryonic implantation: histology, biomarkers, and transcriptomics.  Semin Cell Dev Biol. 2008;  19(2) 204-211
• 161 Campbell K L, Rockett J C. Biomarkers of ovulation, endometrial receptivity, fertilisation, implantation and early pregnancy progression.  Paediatr Perinat Epidemiol. 2006;  20(Suppl 1) 13-25
• 162 Cavagna M, Mantese J C. Biomarkers of endometrial receptivity—a review.  Placenta. 2003;  24(Suppl B) 39-47
• 163 Haouzi D, Mahmoud K, Fourar M et al.. Identification of new biomarkers of human endometrial receptivity in the natural cycle.  Hum Reprod. 2009;  24(1) 198-205
• 164 Bell S C. Secretory endometrial/decidual proteins and their function in early pregnancy.  J Reprod Fertil Suppl. 1988;  36 109-125
• 165 Heffner L J, Iddenden D A, Lyttle C R. Electrophoretic analyses of secreted human endometrial proteins: identification and characterization of luteal phase prolactin.  J Clin Endocrinol Metab. 1986;  62(6) 1288-1295
• 166 Santoro N, MacLaughlin D T, Bauer H H, Hargraves A A, Dichek H L, Richardson G S. In vitro protein production by the human endometrium.  Biol Reprod. 1989;  40(5) 1047-1055
• 167 Beier H M, Beier-Hellwig K, Sterzik S et al.. The significance of endometrial secretion proteins and their determination in human uterine secretions. In: Genazzani AR, Petraglia F Frontiers in Gynecologic and Obstetric Investigation. Carnforth, United Kingdom; Parthenon 1993
• 168 Beier-Hellwig K, Bonn B, Sterzik K et al.. Uterine receptivity and endometrial secretory protein patterns. In: Dey SK Molecular and Cellular Aspects of Preiimplantation Processes. Vol 1. New York, NY; Springer-Verlag 1995
• 169 Carson D D, Lagow E, Thathiah A et al.. Changes in gene expression during the early to mid-luteal (receptive phase) transition in human endometrium detected by high-density microarray screening.  Mol Hum Reprod. 2002;  8(9) 871-879
• 170 Riesewijk A, Martín J, van Os R et al.. Gene expression profiling of human endometrial receptivity on days LH + 2 versus LH + 7 by microarray technology.  Mol Hum Reprod. 2003;  9(5) 253-264
• 171 Schmidt A, Groth P, Haendler B et al.. Gene expression during the implantation window: microarray analysis of human endometrial samples.  Ernst Schering Res Found Workshop. 2005;  (52) 139-157
• 172 Cowan B D, Hines R S, Brackin M N, Case S T. Temporal and cell-specific gene expression by human endometrium after coculture with trophoblast.  Am J Obstet Gynecol. 1999;  180(4) 806-814
• 173 Haendler B, Yamanouchi H, Lessey B A, Chwalisz K, Hess-Stumpp H. Cycle-dependent endometrial expression and hormonal regulation of the fibulin-1 gene.  Mol Reprod Dev. 2004;  68(3) 279-287
• 174 Tabibzadeh S, Sun X Z. Cytokine expression in human endometrium throughout the menstrual cycle.  Hum Reprod. 1992;  7(9) 1214-1221
• 175 Somkuti S G, Yuan L, Fritz M A, Lessey B A. Epidermal growth factor and sex steroids dynamically regulate a marker of endometrial receptivity in Ishikawa cells.  J Clin Endocrinol Metab. 1997;  82(7) 2192-2197
• 176 Daftary G S, Troy P J, Bagot C N, Young S L, Taylor H S. Direct regulation of beta3-integrin subunit gene expression by HOXA10 in endometrial cells.  Mol Endocrinol. 2002;  16(3) 571-579
• 177 Apparao K B, Murray M J, Fritz M A et al.. Osteopontin and its receptor alphavbeta(3) integrin are coexpressed in the human endometrium during the menstrual cycle but regulated differentially.  J Clin Endocrinol Metab. 2001;  86(10) 4991-5000
• 178 Genbacev O D, Prakobphol A, Foulk R A et al.. Trophoblast L-selectin-mediated adhesion at the maternal-fetal interface.  Science. 2003;  299(5605) 405-408
• 179 Lai T H, Zhao Y, Shih IeM, Ho C L, Bankowski B, Vlahos N. Expression of L-selectin ligands in human endometrium during the implantation window after controlled ovarian stimulation for oocyte donation.  Fertil Steril. 2006;  85(3) 761-763
• 180 Foulk R A, Zdravkovic T, Genbacev O, Prakobphol A. Expression of L-selectin ligand MECA-79 as a predictive marker of human uterine receptivity.  J Assist Reprod Genet. 2007;  24(7) 316-321
• 181 Kumar S, Zhu L J, Polihronis M et al.. Progesterone induces calcitonin gene expression in human endometrium within the putative window of implantation.  J Clin Endocrinol Metab. 1998;  83(12) 4443-4450
• 182 Zhu L J, Cullinan-Bove K, Polihronis M, Bagchi M K, Bagchi I C. Calcitonin is a progesterone-regulated marker that forecasts the receptive state of endometrium during implantation.  Endocrinology. 1998;  139(9) 3923-3934
• 183 Li Q, Wang J, Armant D R, Bagchi M K, Bagchi I C. Calcitonin down-regulates E-cadherin expression in rodent uterine epithelium during implantation.  J Biol Chem. 2002;  277(48) 46447-46455
• 184 Chen G TC, Getsios S, MacCalman C D. Cadherin-11 is a hormonally regulated cellular marker of decidualization in human endometrial stromal cells.  Mol Reprod Dev. 1999;  52(2) 158-165
• 185 MacCalman C D, Furth E E, Omigbodun A, Bronner M, Coutifaris C, Strauss III J F. Regulated expression of cadherin-11 in human epithelial cells: a role for cadherin-11 in trophoblast-endometrium interactions?.  Dev Dyn. 1996;  206(2) 201-211
• 186 Birdsall M A, Hopkisson J F, Grant K E, Barlow D H, Mardon H J. Expression of heparin-binding epidermal growth factor messenger RNA in the human endometrium.  Mol Hum Reprod. 1996;  2(1) 31-34
• 187 Kimber S J. Molecular interactions at the maternal-embryonic interface during the early phase of implantation.  Semin Reprod Med. 2000;  18(3) 237-253
• 188 Martin K L, Barlow D H, Sargent I L. Heparin-binding epidermal growth factor significantly improves human blastocyst development and hatching in serum-free medium.  Hum Reprod. 1998;  13(6) 1645-1652
• 189 Lessey B A, Gui Y, Apparao K B, Young S L, Mulholland J. Regulated expression of heparin-binding EGF-like growth factor (HB-EGF) in the human endometrium: a potential paracrine role during implantation.  Mol Reprod Dev. 2002;  62(4) 446-455